|
|
|
| ||||
Last Loaded on Web: Wednesday, May 01, 2013
DIOGENES®: Adverse Drug Events Database consists of two subfiles: Adverse Drug Reactions (ADR) and Adverse Event Reporting System (AERS). ADR records contain data regarding a single patient's experience with a drug or combination of drugs as reported to the U.S. Food and Drug Administration (FDA). Since 1969, the FDA has legally-mandated adverse drug reaction reports from pharmaceutical manufacturers and maintained them in their ADR system. The original reports varied greatly in detail, some providing only minimal details.
In November 1997, the ADR database was replaced by the Adverse Event Reporting System (AERS). AERS events are described on MedWatch form DGA-3500A and contain many more details than appeared on the earlier ADR records. Reports in the AERS file are evaluated by clinical reviewers in FDA's Center for Drug Evaluation. When information is unknown, it is omitted.
Vaccines are reported in a separate system and are not included in ADR data.
USE FILE 181to monitor reported adverse drug reactions. SEARCH /NA or NA=to find suspect or concomittant drug names: S INSULIN/NAS NA=WARFARIN SEARCH /CO or CO=to find specific drug manufacturers or reporting manufacturers: S BAYER/COUSE /AERto restrict to more recent AER data: S BETASERON/AER |
The scope of DIOGENES®: Adverse Drug Events Database is FDA-related data regarding drugs as reported by drug manufacturers, individuals, health professionals, and medical studies. Records provide:
Records also contain manufacturer name, dosage, administration route, and drug lot number, when this information is known.
Data included in ADR records is drawn from the ADR database, which began in 1969. From November 1997 onward, the information is taken from the AERS database, as described above.
| Dates Covered: | ADRs - 1969 through October 1997; AERs - November 1997 to 2008 |
|---|---|
| File Size: | 4,223,207 records |
| Update Frequency: | Closed |
| ACRONYM | CATEGORY NAME |
|---|---|
| PHARMR | Pharmacology + RINGDOC-Files |
| PHARMREG | Pharmaceutical Regulation |
| REGS | Regulations |
| SAFETY | Safety |
| TOXICOL | Toxicology |
|
DIOGENES®: Adverse Drug Events Database is produced by the FOI Services, Inc. Questions concerning file content should be directed to: 704 Quince Orchard Road Suite 275 Gaithersburg, MD 20878
|
All information and record identification in DIOGENES® Adverse Drug Events Database is fully protected by copyright. Reproduction or photocopying even for internal use without the publisher's permission is prohibited. While every effort has been made to ensure that the information in the database is correct, FOI Services, Inc. cannot accept any responsibility for errors or omissions.
| DIALOG(R)File 181:DIOGENES(r) Adverse Drug Events | |
| (c) 2003 The Dialog Corporation. All rts. reserv. | |
| 0002965633 | |
| AA= | FDA Report number: 4058668 |
| PD=,PY= | FDA Receipt Date: October 28, 2002 |
| Report Title: | |
| /TI,/NA,NA=,/NS,NS= | AERS Drug Report. 1 Suspect Drug(s): BETASERON. Total 6 Drug(s) Cited. |
| /CO,CO=,/SM,SM= | Sending Manufacturer: BERLEX LABORATORIES |
| FS= | ADR/AER: AER |
| RC= | Report Code: Expedited (15-day: reported by manufacturer) |
| RS= | Report Source: Consumer; Health Professional; Physician |
| Date on Report: October 23, 2002 | |
| Source/update date: FDA AERS list (20030821) | |
| RN= | Manufacture Report#: USA-2002-002832 |
| FDA Image ID: 4058668-8 | |
| Initial/follow-up: Followup | |
| Follow-up sequence#: 2 | |
| CN= | Case number: 3837144 |
| Electronic submission:No | |
| RD=,RY= | Reaction Date: January 7, 2002 |
| RE= | Reactions: GLIOBLASTOMA |
| OT= | Outcomes: Death |
| Death Date: 20020716 | |
| Patient Information: | |
| AG= | Age: 53 Years |
| SX= | Sex: Female |
| Weight: 46.7 KG | |
| Drug Information: | |
| /NA,NA= | Primary Suspect: BETASERON; Manufacturer Reported: Unknown; Dosage |
| /TX | Reported: 8 MIU, EVERY 2D, SUBCUTANEOUS; Reported Route: SUBCUTANEOUS; |
| N/A Dechallenge Result; N/A Rechallenge Result; Validated Trade Name | |
| Drug Name Source; Unknown Lot Number; Unknown Expiration; Therapy Dates | |
| (Start-End): 19991129-20020716 | |
| /NA,NA= | Concomitant: CLONIDINE; Manufacturer Reported: Unknown; Dosage Reported: |
| /TX | Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown |
| Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot | |
| Number; Unknown Expiration | |
| /NA,NA= | Concomitant: FUROSEMIDE; Manufacturer Reported: Unknown; Dosage Reported: |
| /TX | Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown |
| Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot | |
| Number; Unknown Expiration | |
| /NA,NA= | Concomitant: MIACALCIN; Manufacturer Reported: Unknown; Dosage Reported: |
| /TX | Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown |
| Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot | |
| Number; Unknown Expiration | |
| /NA,NA= | Concomitant: KLOR-CON; Manufacturer Reported: Unknown; Dosage Reported: |
| /TX | Unknown; Reported Route: Unknown; Unknown Dechallenge Result; Unknown |
| Rechallenge Result; Validated Trade Name Drug Name Source; Unknown Lot | |
| Number; Unknown Expiration | |
| /NA,NA= | Concomitant: CALCIUM (CALCIUM); Manufacturer Reported: Unknown; Dosage |
| /TX | Reported: Unknown; Reported Route: Unknown; Unknown Dechallenge Result; |
| Unknown Rechallenge Result; Verbatim Drug Name Drug Name Source; | |
| Unknown Lot Number; Unknown Expiration | |
| SEARCH SUFFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| None | None | All Basic Index Fields | Word | S SUSPECT |
| /CO | CO | Company Name1 | Word | S BERLEX/CO |
| /NA | DI | Drug Name1,2 | Word | S BETASERON/NA |
| /NS | DI | Named Suspect Drug1 | Word | S BETASERON/NS |
| /SM | SM | Sending Manufacturer1,3 | Word | S BERLEX/SM |
| /TI | TI | Title | Word | S BETASERON/TI |
| /TX | TX,NT | Text of Drug Information and Notes4 | Word | S SUBCUTANEOUS/TX |
1 Searchable in the Basic Index and in the Additional Indexes.
2 Includes Named Suspect Drug (NS=).
3 Present only in AER subfile records.
4 Notes are present only in ADR subfile records.
| SEARCH PREFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| AA= | AA | Supplier Accession Number/FDA Report Number | Phrase | S AA=4058668 |
| AG= | AG | Age | Phrase | S AG=030:040 |
| None | AZ | DIALOG Accession Number | ||
| CN= | CN | Case Number | Phrase | S CN=3837144 |
| CO= | CO | Company Name1 | Phrase | S CO=BERLEX LAB? |
| None | DD | Death Date | ||
| None | DI | Drug Information | ||
| None | DR | Date on Report | ||
| FI= | FI | Follow-up/Initial Report | Phrase | S FI=INITIAL |
| FS= | FS | Subfile/File Segment | Phrase | S FS=AER |
| LA= | LA | Language | Phrase | S LA=ENGLISH |
| NA= | DI | Drug Name1,2 | Phrase | S NA=BETASERON? |
| NS= | DI | Named Suspect Drug1 | Phrase | S NS=BETASERON? |
| OT= | OT | Outcome | Phrase | S OT=(DEATH OR DIED) |
| PD= | PD | FDA Receipt Date | Phrase | S PD=20021028 |
| PY= | PY | FDA Receipt Year | Phrase | S PY=2002 |
| RC= | RC | Report Code | Phrase | S RC=EXPEDITED? |
| RD= | RD | Reaction Date | Phrase | S RD=20020107 |
| RE= | RE | Reaction | Phrase | S RE=GLIOBLASTOMA |
| RN= | RN | Manufacturer Report Number | Phrase | S RN=USA-2002-002832 |
| None | RP | Report Type | ||
| RS= | RS | Report Source | Phrase | S RS=CONSUMER |
| RY= | RY | Reaction Year | Phrase | S RY=2002 |
| SM= | SM | Sending Manufacturer1,3 | Phrase | S SM=BERLEX? |
| None | SO | Source Information | ||
| SX= | SX | Sex | Phrase | S SX=FEMALE |
| UD= | None | Update | Phrase | S UD=9999 |
| None | WT | Weight |
| SUFFIX | FIELD NAME | EXAMPLES |
|---|---|---|
| /ADR | ADR Subfile Record | S S2/ADR |
| /AER | AER Subfile Record | S S2/AER |
| /YYYY | Publication Year | S S3/2002 |
| SORTABLE FIELDS | EXAMPLES |
|---|---|
| AA, NA, PD, PY | SORT S6/ALL/PY PRINT S3/5/1-24/NA |
| RANK FIELDS | EXAMPLES |
|---|---|
| All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. | RANK CO S3 |
| User-defined formats may be specified using the display codes indicated in the Search Options tables. | TYPE S3/NA,TI,RE/1-5 |
| NO. |
DIALOGWEB FORMAT |
RECORD CONTENT |
|---|---|---|
| 1 | -- | DIALOG Accession Number |
| 2 | -- | Suspect Drug Name, Title, Dates, Report Code, Report Source, Manufacturer Report Number, FDA Request Number, Sending Manufacturer, Reaction Data and Outcomes, and Patient Information |
| 3 | Medium | Suspect Drug Name, Title, Dates, Report Code, Report Source, Manufacturer Report Number, FDA Request Number, and Sending Manufacturer |
| 4 | -- | Full Record with Tagged Fields |
| 5 | -- | Full Record with Drug Information Text (includes if known Concomittant Drugs, Manufacturer Reported, Dosage, Reported Route, and Therapy Dates) |
| 6 | Free | Suspect Drug Name, Title, and FDA Receipt Date |
| 7 | -- | Suspect Drug Name, Title, Dates, Report Code, Report Source, Manufacturer Report Number, FDA Request Number, Sending Manufacturer, Reaction Data and Outcomes, and Patient Information |
| 8 | Short | Title and Sending Manufacturer |
| 9 | Full | Full Record with Drug Information Text (includes if known Concomittant Drugs, Manufacturer Reported, Dosage, Reported Route, and Therapy Dates) |
| K | -- | KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats |
| FIELD NAME | EXAMPLES | ||
|---|---|---|---|
| DIALOG Accession Number | TYPE 120491/5 DISPLAY 119604/TI PRINT 117590/3 |
||
Rates For File: DIOGENES®: Adverse Drug Events Database[181]
Cost per DialUnit: $16.96
Cost per minute: $3.83
Rank Elements $0.04
Format Types Prints
1 $0.00 $0.00
2 $1.50 $1.50
3 $1.50 $1.50
4 $1.50 $1.50
5 $1.50 $1.50
6 $0.00 $0.00
7 $1.50 $1.50
8 $1.50 $1.50
9 $1.75 $1.75
KWIC95 $1.50 NA
KWIC96 $1.50 NA
REDIST/COPY Multiplier Table:
Range Multiplier
1-2 1.00
3-25 1.50
26-100 3.00
101-200 4.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
ARCHIVE Multiplier Table:
Range Multiplier
1-25 1.50
26-200 3.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
